M80: Development of broadly nanobodies (VHH) against HIV-1 for prophylactic and therapeutic applications of HIV-1 infections
Dokumentation 2016–2020
Projektleiter:
Dr. Ursula Dietrich
Institut für Tumorbiologie und experimentelle Therapie sowie molekulare Virologie
Georg-Speyer-Haus
Paul-Ehrlich-Str. 42-44
60596 Frankfurt
Projekttitel:
Development of broadly neutralizing nanobodies (VHH) against HIV-1 for prophylactic and therapeutic applications of HIV-1 infections
Projektdauer:
01/2017 – 2020
Veröffentlichungen:
Koch K, Kalusche S, Torres JL, Stanfield RL, Danquah W, Khazanehdari K, von Briesen H, Geertsma ER, Wilson IA, Wernery U, Koch-Nolte F, Ward AB, Dietrich U.
Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers
Scientific Reports 2017, 7:8390 doi: 10.1038/s41598-017-08273-7
Sarah Kalusche, Kanika Vanshylla, Franziska Kleipass, Henning Grüll, Barbara Müller, Zhu Zeng, Kathrin Koch, Stefan Stein, Harold Marcotte, Florian Klein, Ursula Dietrich
Lactobacilli expressing broadly neutralizing nanobodies against HIV-1 as potential vectors for HIV-1 prophylaxis?
Vaccines 2020, 8, 758; doi: 10.3390/vaccines8040758
zurück zur Übersicht